Back to the North Carolina Tar Heels Newsfeed

Carolina Research Leads to Effective Experimental Pill to Treat COVID-19

Tar Heel Times | October 2, 2021

Related Topics: COVID-19, University of North Carolina at Chapel Hill, University of North Carolina School of Medicine, Food and Drug Administration, Franklin Street, Bubba Cunningham, UNC Health Care

Scientists at UNC-Chapel Hill say a twice-daily pill – molnupiravir — could change the way COVID-19 is treated. Friday's announcement by Merck to seek emergency authorization by the Food and Drug Administration reflects early research and testing conducted at UNC. William Fischer, MD, at the UNC School of Medicine led pivotal clinical trials. (UNC Health Care) UNC Sports Medicine Director helped keep student-athletes safe and competitive during pandemic
Throughout the COVID-19 pandemic, the first and last calls Carolina Athletic Director Bubba Cunningham made each day were to Dr. Mario Ciocca. As director of.

See full article at Tar Heel Times